The safety of antimalarial drugs in pregnancy

Drug Safety

Volumn 14, Issue 3, 1996, Pages 131-145

  Phillips Howard, Penelope A ^a,b   Wood, Dawn ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; CHLOROQUINE; CHLORPROGUANIL; DAPSONE; DOXYCYCLINE; HALOFANTRINE; MEFLOQUINE; PRIMAQUINE; PROGUANIL; PYRIMETHAMINE; QUININE; SULFADOXINE; SULFONAMIDE; SULFONE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

BIRTH DEFECT; BREAST MILK; DRUG SAFETY; FEMALE; FETOTOXICITY; FETUS; FIRST TRIMESTER PREGNANCY; HEARING IMPAIRMENT; HEMOLYTIC ANEMIA; HUMAN; HYPOGLYCEMIA; KERNICTERUS; MALARIA; MALARIA CONTROL; OPTIC NERVE HYPOPLASIA; OTOTOXICITY; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; TERATOGENICITY;

EID: 0029866818     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199614030-00001     Document Type: Review

References (101)

1. McGregor IA, Wilson ME, Billewicz WZ, et al. Malaria infection of the placenta in The Gambia, west Africa: its incidence and relationship to stillbirth, birthweight, and placental weight. Trans R Soc Trop Med Hyg 1983; 77: 232-44
2. Gilles HM, Lawson JB, Sibelas M, et al. Malaria, anaemia and pregnancy. Ann Trop Med Parasitol 1969; 63: 254-63
3. Brabin BJ. The risks and severity of malaria in pregnant women. Applied Field Research in Malaria Reports, No. 1. UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). Geneva, 1991
4. Nathwani D, Currie PF, Douglas JG, et al. Plasmodium falciparum malaria in pregnancy: a review. Br J Obstet Gynaecol 1992; 99: 118-21
5. World Health Organization. Practical chemotherapy of malaria. Report of a WHO scientific group. 1990 Technical Report Series, No. 805
6. World Health Organization. International travel and health. Geneva: World Health Organization, 1995
7. World Health Organization. Antimalarial drug policies: data requirements, treatment of uncomplicated malaria and management of malaria in pregnancy. Geneva: World Health Organization, 1994 Report no.: WHO/MAL/94.1070
8. Garner P, Brabin B. A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas. Bull World Health Organ 1994; 72: 89-99
9. Briggs GC, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 2nd ed. Baltimore: Williams and Wilkins, 1986: 537-53
10. Reynolds J. Martindale. The extra pharmacopoeia. 29th ed. London: The Pharmaceutical Press, 1989
11. Looareesuwan S, Phillips RE, White NJ, et al. Quinine and severe falciparum in late pregnancy. Lancet 1985; 2: 4-8
12. Davis TM, Suputtamongkol Y, Spencer JL, et al. Glucose turnover in pregnant women with acute malaria. Clin Sci (Colch) 1994; 86: 83-90
13. Phillips RE, Looareesuwan S, White NJ, et al. Quinine pharmacokinetics and toxicity in pregnant and lactating women with falciparum malaria. Br J Clin Pharmacol 1986; 21: 677-83
14. Dyban AP. Embryotoxic and teratogenic activity of certain antimalarial drugs [unpublished document]. World Health Organization, 1967
15. Shao B, Zhan C, Ha S, et al. The embryotoxicity of chloroquine and pyrimethamine in rats. Chi Sheng Chung Hsueh Yu Chi Sheng Chung Ping Tsa Chih 1983; 1: 134-37
16. Linquist JG, Ullberg S. The melanin affinity of chloroquine and chlorpromazine studied by whole body autoradiography. Acta Pharmacol 1972; 31 Suppl. 2: 1-31
17. Okanlawon AO, Ejiwunmi AB, Dada MO, et al. Morphometric analysis of the effect of chloroquine on rat foetal lung maturation. East Afr Med J 1993; 70: 98-100
18. Hart W, Naunton RF. The ototoxicity of chloroquine phosphate. Arch Otolaryngol Head Neck Surg 1964; 80: 407-12
19. Lindsay J. Profound childhood deafness. Inner ear pathology. Ann Otol Rhinol Laryngol 1973; 82 Suppl. 5: 11-21
20. Parke AL. Antimalarial drugs, pregnancy and lactation. Lupus 1993; 2 Suppl. 1: S21-3
21. Parke A. Antimalarial drugs and pregnancy. Am J Med 1988; 85 Suppl. 4A: 30-3
22. Levy M, Buskila D, Gladman DD, et al. Pregnancy outcome following first trimester exposure to chloroquine. Am J Perinatol 1991; 8: 174-8
23. Petri M. Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am 1994; 20: 87-118
24. Wolfe M, Cordero J. Safety of chloroquine in chemosuppression of malaria during pregnancy. BMJ 1985; 290: 1466
25. Phillips-Howard PA, Steffen R, Kerr L. et al. Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy Bull World Health Organ. In press
26. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littlelon (MA): Publishing Sciences Group, Inc., 1977
27. Steketee RW, Wirima JJ. Malaria prevention in pregnancy: the effects of treatment and chemoprophylaxis on placental malaria infection, low birth weight, and fetal, infant, and child survival. United States Agency for International Development Africa Regional Project (698-0421), US Department of Health and Human Services, 1994
28. Cot M, Roisin A, Barro D, et al. Effect of chloroquine chemoprophylaxis during pregnancy on birth weight: results of a randomized trial. Am J Trop Med Hyg 1992; 46: 21-7
29. McDermott JM, Heymann DL, Wirima JJ, et al. Efficacy of chemoprophylaxis in preventing Plasmodium falciparum parasitaemia and placental infection in pregnant women in Malawi. Trans R Soc Trop Med Hygiene 1988; 82: 520-3
30. Heymann DL, Khoromana CO, Wirima JJ, et al. Comparative efficacy of alternative primary therapies for Plasmodium falciparum infections in Malawi. Trans R Soc Trop Med Hyg 1987; 81: 722-4
31. Steketee RW, Brandling-Bennett AD, Kaseje DCO, et al. In vivo response of Plasmodium falciparum malaria to chloroquine in pregnant and non pregnant women in Siaya District, Kenya. Bull World Health Organ 1987; 65: 885-90
32. Martin GE, Nwake CC. Administration de la dose unique mensuelle de 600 mg de chloroquine base dans le controle du paludisme chez les femmes encientes (OCEAC). Bull Liaison Documentation 1982; 53: 41-7
33. Soares R, Paulini E, Pereira JP, et al. Concentration and elimination of chloroquine by the placental circulation and the milk in patients receiving chloroquinized salt. Rev Bras Malariol Doencas Trop 1957; 9: 19-27
34. Walter Reed Army Institute for Research. Appendix E. Mefloquine. Background information. New drug application to the US Food and Drug Administration [unpublished]. Washington: Walter Reed Army Institute of Research, 1986
35. Balocco R, Bonati M. Mefloquine prophylaxis against malaria for female travellers of childbearing age. Lancet 1992; 340: 309-10
36. Clyde DF. Clinical problems associated with the use of primaquine as a tissue schizomocidal and gametocytocidal drug. Bull World Health Organ 1981; 59: 391-5
37. Prins HK, Oort M, Loos JA, et al. Congenital non-spherocytic haemolytic anemia, associated with glutathione deficiency of the erythrocytes. Blood 1966; 27: 145
38. Cutting W. Antifertility effects of biguanides. Antibiotics and chemotherapy 1962; XII (12): 671-5
39. Chebotar NA. Embryonic and teratogenic action of proguanil, chlorproguanil, and cycloguanil on albino mice. Bull Exp Biol Med 1974; 77: 56-7
40. Wangboonskul J, White NJ, Nosten F, et al. Single dose pharmacokinetics of proguanil and its metabolites in pregnancy. Eur J Clin Pharmacol 1993; 44: 247-51
41. Thiersch JB. Effects of certain 2,4-diaminopyrimidine antagonist of folic acid on pregnancy and rat fetus. Proc Soc Exp Biol 1954; 87: 571-7
42. Krahe M. Utersuchungen uber die teratogen Wirkung von medikamenten zur behandling der toxoplasmose wahrend der schwangerschaft [in German]. Arch Gynakol 1965; 202: 104-9
43. Hengst P. Untersuchungen zur Teratogenität des Daraprim (Pyrimethamine) beim Menschen. Zentralbl Gynakol 1972; 94: 551-5
44. Morely D, Woodland M, Cuthbertson WFJ. Controlled trial of pyrimethamine in pregnant women. BMJ 1964; 1: 667-8
45. Fleming A, Ghatoura GBS, Harrison KA. The prevention of megaloblastic anaemia in pregnancy. Niger J Obstet Gynaecol 1968; 75: 425-32
46. Nahlen BL, Akintunde A, Alakija T, et al. Lack of efficacy of pyrimethamine prophylaxis in pregnant Nigerian women. Lancet 1982; 2: 830-3
47. Harpey J-P, Darbois Y, Lefebvre G. Teratogenicity of pyrimethamine. Lancet 1983; 2: 399
48. Bertazzoli C, Chieli T, Grandi M. Absence of tooth malformation in offspring of rats treated with long-acting sulphonamide. Experientia 1965; 21: 151-2
49. Bohni E, Fust B, Rieder J. Comparative toxicological, chemotherapeutic and pharmacokinetic studies with sulfamethoxine and other sulphonamides in animals and man. Chemotherapy 1969; 14: 195-226
50. Kato T, Kitagawa S. Production of congenital abnormalities in fetuses of rats and mice with various sulfonamides. Congenital Anomalies 1973; 13: 7-13
51. Saxen L. Association between clefts and drugs taken during pregnancy. Int J Epidemiol 1975; 4: 37-44
52. Nelson MM, Forfar JO. Association between drugs administered in pregnancy and congenital abnormalities. BMJ 1971: 5748; 523-7
53. Baskin CG, Law S, Wenger NK, et al. Sulfadiazine rheumatic fever prophylaxis during pregnancy: does it increase the risk of kernicterus in the newborn? Cardiology 1980; 65: 222-5
54. Thornton YS, Bowe ET. Neonatal hyperbilirubinemia after treatment of maternal leprosy. South Med J 1989; 82: 668
55. Fraser PJ. Effects of pyrimethamine and sulpormethoxine at a 1:20 mixture of pyrimethamine and sulfamethoxine in pregnant animals [unpublished document]. Beckenham: Wellcome Research Labs, 1969
56. Barbosa JC, Ferriera I. Sulfadoxine-pyrimethamine (Fansidar) in pregnant women with toxoplasma antibody titres. In: Siegenthaler W, Luthy R, editors. Current chemotherapy. Vol. I. American Society of Microbiology, 1978: 134-5
57. Cohlan SQ, Bevelander G, Tiamsic T. Growth inhibition of prematures receiving tetracycline. Am J Dis Child 1963; 105: 453-61
58. Krejci L. Eye changes due to systemic use of tetracyclines in pregnancy. Animal trials. Ophthalmic Res 1980; 12: 73-7
59. Westland MM. Effects of tetracycline on chromosomes cultured from human lymphocytes. J Am Med Wom Assoc 1967; 22: 719
60. Charles D, Obst D. Placental transmission of antibiotics. J Obstet Gynaecol 1954; 61: 750-7
61. Seeliger RPH, Ronde G. Die Wirkung von Tetracyclingaben auf das kindliche Gebiss bei Listeriosebehandlung von Schwangeren. Geburtshilfe Frauenheilkd 1968; 28: 209
62. Carter MP, Wilson F. Tetracycline and congenital limb abnormality. BMJ 1962; 2: 407-8
63. Corcoran R, Castles JM. Tetracycline for acne vulgaris and possible teratogenesis. BMJ 1977; 2: 807-8
64. Krejci L, Brettschneider I. Congenital cataract due to tetracycline. Ophthalmic Paediatr Genet 1983; 3: 59-60
65. Kutscher AH, Zagarelli EV, Tovell MMM, et al. Discolouration of teeth induced by tetracycline. JAMA 1963; 184: 586
66. Seo ML, Yamatodani A, Mizutani A, et al. Short-term, preweaning treatment with tetracycline affects physical development and behavior in rats. Neurotoxicology 1993; 14: 65-75
67. Bastianini L, Felisati D. Studi sulla tossicita gravidica e fetale dell α-6-deossi-5-ossitetraciclina (doxiciclina) nei topo e nel coniglio [multilingual; non-English]. Antibiotica 1970; 8: 161-78
68. Bocker R, Estler CJ, Muller S, et al. Comparative evaluation of the effects of tetracycline, rolitetracycline and doxycycline on some blood parameters related to liver function. Arzneimittel Forschung 1982; 32: 237-41
69. Schuster BG, Canfield CJ. Preclinical studies with halofantrine In: Warhurst DC, Schofield CJ, editors. Halofantrine in the treatment of multidrug resistant malaria. Cambridge: Elsevier, 1989: 3-13
70. Yang Q-C. The antimalarial and toxic effects of artesunate on animal models. J Tradit Chin Med 1982; 22: 99-103
71. Hein TT, White NJ. Qinghaosu. Lancet 1993; 341: 603-8
72. China Cooperative Research Group on Qinghaosu and its derivatives as antimalarials. J Trad Chin Med 1982; 2: 1-50
73. Wang T-Y. Therapeutic effectiveness and toxic side-effects of artemisinin and artemether for their treatment of malaria patients in pregnancy. J Trad Chin Med 1989; 9: 28-30
74. Li Guo-Qiao, editor. Clinical trials on qinghaosu and its derivatives, Vol 1. Guangzhou College of Traditional Chinese Medicine, Sanya Tropical Medicine Institute, China, 1990
75. Guo-Qiao L, Xing-Bo G, Lin-Chun F, et al. Clinical trials of artemisinin and its derivatives in the treatment of malaria. Trans R Soc Trop Med Hyg 1994; 88 Suppl. 1: 5-6
76. White NJ, Looareesuwan S, Warrell DA, et al. A quinine loading dose in cerebral malaria. Am J Trop Med Hyg 1983; 32: 1-5
77. Kline J, Stein Z, Susser M. Conception to birth: epidemiology of prenatal development. Monographs in epidemiology and biostatistics. Vol. 14. New York: Oxford University Press, 1990
78. Nosten F, ter Kuile F, Maelankiri L, et al. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. J Infect Dis 1994; 169: 595-603
79. Collignon P, Hehir J, Mitchell D. Successful treatment of falciparum malaria in pregnancy with mefloquine [letter]. Lancet 1989; 1: 967
80. Watkins WM, Brandling-Bennett AD, Nevill CG, et al. Chlorproguanil/dapsone for the treatment of non severe Plasmodium falciparum infection in Kenya: a pilot study. Trans R Soc Trop Med Hyg 1988; 82: 398-403
81. Harinasuta T, Bunnag D, Karbwang J, et al. A clinical trial of mefloquine on multidrug resistant falciparum malaria in pregnant women in Thailand. Bull Soc Francaise Parasitol 1990; 8: 429
82. Dorangeon PH, Marx-Chemla C, Quereux C, et al. Les risques de l'association pyrimethamine-sulfadoxine dans le traitement antenatal de la toxoplasmose [in French]. J Gynecol Obstet Biol Reprod (Paris) 1992; 21: 549-56
83. Maurus JN. Hansons disease in pregnancy. Obstet Gynaecol 1978; 2: 22-5
84. Miller K, Lobel HO, Satraile RF, et al. Severe cutaneous reactions among American travellers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. Am J Trop Med Hyg 1986; 35: 451-8
85. Greenwood B, Greenwood AM, Snow RW. The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy. Trans R Soc Trop Med Hyg 1989; 83: 589-94
86. Greenwood AM, Menendez C, Todd J, et al. The distribution of birth weights in Gambian women who received malaria chemoprophylaxis during their first pregnancy and in control women. Trans R Soc Trop Med Hyg 1994; 88: 311-2
87. Menendez C, Todd J, Alonso PL, et al. Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae. J Trop Med Hyg 1994; 97: 244-8
88. Sowunmi A, Akindele JA, Omitowoju GO, et al. Intramuscular sulfadoxine-pyrimethamine in uncomplicated chloroquine-resistant falciparum malaria during pregnancy. Trans R Soc Trop Med Hyg 1993; 87: 472
89. Keuter M, van Eijk A, Hoogstrate M, et al. Comparison of chloroquine, pyrimethamine-sulfadoxine, and chlorproguanil and dapsone in pregnant and non-pregnant women, Kakamega district, Kenya. BMJ 1990; 301: 466-70
90. Schultz LJ, Steketee RW, Macheso A, et al. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 1994; 51: 515-22
91. Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet 1993; 341: 1299-303
92. Whalley PJ, Adams RH, Combes B. Tetracycline toxicity in pregnancy. JAMA 1964; 189: 357-62
93. Dowling HF, Lepper MH. Hepatic reactions to tetracycline. JAMA 1964; 188: 307-8
94. Kunelis CT, Peters JL, Edmondson HA. Fatty liver of pregnancy and its relationship to tetracycline therapy. Am J Med 1965; 38: 359-77
95. Riond J-L, Riviere JE. Pharmacology and toxicology of doxycycline. Vet Hum Toxicol 1988; 30: 431-43
96. Looareesuwan S, Viravan C, Vanijanonta S, et al. Randomized trial of mefloquine-doxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria. Am J Trop Med Hyg 1994; 50: 784-9
97. Mvondo JL, James MA, Campbell CC. Malaria and pregnancy in Cameroonian women. Effect of pregnancy on Plasmodium falciparum parasitaemia and the response to chloroquine. Trop Med Parasitol 1992; 43: 1-5
98. Schultz LJ, Steketee RW, Chitsulo L, et al. Malaria and child-bearing women in Malawi: knowledge, attitudes and practices. Trop Med Parasitol 1994; 45: 65-9
99. World Health Organization. The role of artemisinin and its derivatives in the current treatment of malaria (1994-1995). Geneva: World Health Organization, 1994. Report no. WHO/MAL/94.1067
100. Severe anaemia in pregnancy: a problem of primigravidae in rural Zaire. Trans R Soc Trop Med Hyg 1991; 85: 829-32
101. Greenwood AM, Menendez C, Alonso PL, et al. Can malaria chemoprophylaxis be restricted to first pregnancies? Trans R Soc Trop Med Hyg 1994; 88: 681-2